Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 1, 2007, Pages 155-161

  Schmoker, Joseph D ^a,b   McPartland, Kenneth J ^a,b   Fellinger, Erika K ^a,b   Boyum, Jon ^a,b   Trombley, Lucy ^a,b   Ittleman, Frank P ^a,b   Terrien III, Christopher ^a,b   Stanley, Andrew ^a,b   Howard, Alan ^a  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA ANEURYSM;

AGED; AORTIC ANEURYSM, THORACIC; ATHEROSCLEROSIS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33845743071     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.07.036     Document Type: Article

References (29)

1. Newman K.M., Jean-Claude J., Li H., Scholes J.V., Ogata Y., Nagase H., et al. Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall. J Vasc Surg 20 (1994) 814-820
2. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., and Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15 (1995) 1145-1151
3. Shah P.K. Inflammation, metalloproteinases, and increased proteolysis: an emerging paradigm in aortic aneurysm. Circulation 96 (1997) 2115-2117
4. Galis Z.S., and Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90 (2002) 251-262
5. Elmore J.R., Keister B.F., Franklin D.P., Youkey J.R., and Carey D.J. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 12 (1998) 221-228
6. Lesauskaite V., Tanganelli P., Sassi C., Neri E., Diciolla F., Ivanoviene L., et al. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Hum Pathol 32 (2001) 1003-1011
7. Boyum J., Fellinger E.K., Schmoker J.D., Trombley L., McPartland K., Ittleman F.P., et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 127 (2004) 686-691
8. Koullias G.J., Ravichandran P., Korkolis D.P., Rimm D.L., and Elefteriades J.A. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 78 (2004) 2106-2111
9. LeMaire S.A., Wang X., Wilks J.A., Carter S.A., Wen S., Won T., et al. Matrix metalloproteinase in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. J Surg Res 123 (2005) 40-48
10. Segura A.M., Luna R.E., Horiba K., Stetler-Stevenson W.G., McAllister Jr. H.A., Willerson J.T., et al. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation 98 (1998) II331-II337
11. Absi T.S., Sundt T.M., Tung W.S., Moon M., Lee J.K., Damiano R.R., et al. Altered patterns of gene expression distinguishing ascending aortic aneurysm from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 126 (2003) 344-357
12. Ikonomidis J.S., Gibson W.C., Butler J.E., McClister D.M., Sweterlitsch S.E., Thompson R.P., et al. Effects of deletion of the tissue inhibitor of matrix metalloproteinase-1 gene on the progression of murine thoracic aortic aneurysms. Circulation 110 (2004) II268-II273
13. Silence J., Collen D., and Lijnen H.R. Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene. Circ Res 90 (2002) 897-903
14. Wang M., and Lakatta E.G. Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension 39 (2002) 865-873
15. Wang M., Takagi G., Asai K., Resuello R.G., Natividad F.F., Vatner D.E., et al. Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 41 (2003) 1308-1316
16. McNulty M., Spiers P., McGovern E., and Feely J. Aging is associated with increased matrix metalloproteinase-2 activity in the human aorta. Am J Hypertens 18 (2005) 504-509
17. Spiers J.P., Kelso E.J., Siah W.F., Edge G., Song G., McDermott B.J., et al. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade. J Hypertension 23 (2005) 1717-1724
18. Yasmin, Wallace S., McEniery C.M., Dakham Z., Pusalkar P., Maki-Petaja K., et al. Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness. Arterioscler Thromb Vasc Biol 25 (2005) 372-378
19. Fedak P.W.M., de Sa M.P.L., Verma S., Nili N., Kazemian P., Butany J., et al. Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. J Thorac Cardiovasc Surg 126 (2003) 797-805
20. Ailawadi G., Knipp B.S., Lu G., Roelofs K.J., Ford J.W., Hannawa K.K., et al. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity. J Vasc Surg 37 (2003) 1059-1066
21. Sinha I., Bethi S., Cronin P., Williams D.M., Roelofs K., Ailawadi G., et al. A biologic basis for asymmetric growth in descending thoracic aortic aneurysms: a role for matrix metalloproteinase 9 and 2. J Vasc Surg 43 (2006) 342-348
22. Pearson A.C., Guo R., Orsinelli D.A., Binkley P.F., and Pasierski T.J. Transesophageal echocardiographic assessment of the effects of age, gender, and hypertension on thoracic aortic wall size, thickness, and stiffness. Am Heart J 128 (1994) 344-351
23. Astrand H., Ryden-Ahlgren A., Sandgren T., and Lanne T. Age-related increase in wall stress of the human abdominal aorta: an in vivo study. J Vasc Surg 42 (2005) 926-931
24. Li Z., Froehlich J., Galis Z.S., and Lakatta E.G. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 33 (1999) 116-123
25. Corcoran M.L., and Stetler-Steverson W.G. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism. J Biol Chem 270 (1995) 13453-13459
26. Bonderman D., Gharehbaghi-Schnell E., Wollenek G., Mauer G., Baumgartner H., and Lang I.M. Mechanisms underlying aortic dilation in congenital aortic valve malformation. Circulation 99 (1999) 2138-2143
27. Nataatmadja M., West M., West J., Summers K., Walker P., Nagata M., et al. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm. Circulation 108 (2003) II329-II334
28. Bunton T.E., Biery N.J., Myers L., Gayraud B., Ramirez F., and Dietz H.C. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan Syndrome. Circ Res 88 (2001) 37-43
29. Higashikata T., Yamagishi M., Sasaki H., Minatoya K., Ogino H., Ishibashi-Ueda H., et al. Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysms. Atherosclerosis 177 (2004) 353-360